Bellevue Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bellevue Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,600	Closed	-$1.21M	–	155
2018 Q4	$1.21M	Buy	+8,600	New	+$1.31M	0.08%	111

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Bellevue Group's LOXO Position: Q1 2019 in Review

Bellevue Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 8,600 shares — an estimated $1.21M sold.

Bellevue Group first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $1.21M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Bellevue Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Bellevue Group sold 8,600 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.21M.
Bellevue Group first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
Bellevue Group's Loxo Oncology, Inc position peaked at $1.21M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Bellevue Group's 13F filing for Q1 2019, filed 15 May 2019.